-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G0ek9Oo1P3+7J+xJ0TbB4PrWMT+N5h3wjS9RFJkptCLQNGPZbMqV8WxfuWoPSOIA 6S46AXp4V39Ga7y8yBJCqg== 0001074683-00-000115.txt : 20000215 0001074683-00-000115.hdr.sgml : 20000215 ACCESSION NUMBER: 0001074683-00-000115 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NEOPHARM INC CENTRAL INDEX KEY: 0000942788 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 510327886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-49245 FILM NUMBER: 542913 BUSINESS ADDRESS: STREET 1: 100 CORPORATE NORTH STREET 2: STE 215 CITY: BANNOCKBURN STATE: IL ZIP: 60015 BUSINESS PHONE: 8472958678 MAIL ADDRESS: STREET 1: C/O WILSON SONSIN GOODRICH & ROSETI STREET 2: 650 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: FIRST UNION CAPITAL MANAGEMENT GROUP CENTRAL INDEX KEY: 0001074683 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ONE FIRST UNION CENTER STREET 2: 301 S. COLLEGE ST. CITY: CHARLOTTE STATE: NC ZIP: 28288-0137 SC 13G 1 THIS PAPER DOCUMENT IS BEING SUBMITTED PURSUANT TO RULE 901 9(d) OF REGULATION S-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Neopharm, Inc. (Name of Issuer) Common Stock, Par Value $0.0002 per share (Title of Class of Securities) 640919106 (CUSIP Number) (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X ] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) CUSIP No. 640919106 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). First Union Corporation 56-0898180 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) 3. SEC Use Only 4. Citizenship or Place of Organization North Carolina Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 622500 6. Shared Voting Power 0 7. Sole Dispositive Power 622500 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 622500 10. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) Not Applicable. 11. Percent of Class Represented by Amount in Row (11) 5.66% 12. Type of Reporting Person (See Instructions) Parent Holding Company (HC) Item 1. (a)Name of Issuer Neopharm, Inc. (b) Address of Issuer's Principal Executive Offices 100 Corporate North Suite 215 Bannockburn, Illinois 60015 Item 2. (a) Name of Person Filing First Union Corporation (b) Address of Principal Business Office or, if none, Residence One First Union Center Charlotte, North Caronlina 28288-0137 (c) Citizenship North Carolina (d) Title of Class of Securities Common Stock, Par Value $.01 per share (e) CUSIP Number 337358105 Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or c), check whether the person filing is a: (g)[X ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 622500. (b) Percent of class: 5.66%. (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote 622500. (ii) Shared power to vote or to direct the vote 0. (iii) Sole power to dispose or to direct the disposition of 622500. (iv) Shared power to dispose or to direct the disposition of 0. Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not Applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company First Union Corporation is filing this schedule pursuant to Rule 13d-1(b)(1) (ii)(G) as indicated under item 3(g). The relevant subsidiary is Evergreen Investment Management Company (IA). Evergreen Investment Management Company is an investment advisor for mutual funds and other clients; the securities reported by this subsidiary are beneficially owned by such mutual funds or other clients. Item 8. Identification and Classification of Members of the Group Not Applicable. Item 9. Notice of Dissolution of Group Not Applicable. Item 10. Certification (a) The following certification shall be included if the statement is filed pursuant to 240.13d-1(b): By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. 02/14/2000 Date Signature Karen F. Knudtsen, Assistant Vice President & Trust Officer Name/Title -----END PRIVACY-ENHANCED MESSAGE-----